Ganglioneuroblastoma — Trials

Ganglioneuroblastoma — Trials · CancerIndex

Clinical trials

Registered studies

20 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 6
Ph III recruiting: 4
Growth YoY: —
Industry share: 8%
Top sponsor: Children's Oncology Group
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07502287	Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma(DUAL-NK-NB)	recruiting	Phase 1 / Phase 2	36	Beijing BiotechINDUSTRY	1	Mar 30, 2026	clinicaltrials

Data updated 23 days agoSource updated Mar 30, 2026source: clinicaltrials